TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Dec 07, 2017 11:00 JST
Source:
TAITRA
Taiwan Health Industry Group Visits Malaysia to Promote Medical Tourism
Taiwan's competitive fees for medical services draws patients globally
KUALA LUMPUR, Dec 07, 2017 - (ACN Newswire) - Taiwan External Trade and Development Council (TAITRA) has led a group of medical experts from nine Taiwanese hospitals and clinics in a visit to Malaysia to establish links with local medical institutions and introduce more patients to Taiwan. As part of the visit, medical professionals also shared their success stories as well as medical experiences at the Taiwan Health Industry Forum which was held at the Kuala Lumpur Convention Center.
The Taiwanese delegation includes representatives from Taiwan University Hospital, E-DA Hospital, Kaohsiung Municipal Siaogang Hospital, Lee Women's Hospital, Aphrodite Medical Group, Royal 101 International Health, Biotegy Corporation and Healthcare Industry Development Association.
TAITRA's President and Chief Executive Officer Walter Yeh said, "Taiwan has gained good recognition and credibility among the medical community for its world-class medical systems and technology. There are already 15 medical institutions in Taiwan that have achieved the gold standard in global health care certifications from JSI (Joint Commission International)."
According to Taiwan government statistics, there were over 300,000 tourists who visited Taiwan for health screening and medical services last year. More than three percent of these overseas patients, or 10000 patients, were from Malaysia.
The Taiwan Health Industry Group provides a full range of health services with the latest medical technology equipment for those who are specifically looking for medical treatment in Taiwan. The country's medical strengths include plastic surgery, infertility treatment, hair transplant, weight loss treatments.
Another favorable reason for choosing Taiwan is its competitive pricing for medical services, which can be as low as one-fifth of North America's rate. As such, Taiwan has been a draw for patients from Hong Kong, Macau, Indonesia, Philippines, Malaysia and even America for its premium medical attention at relatively lower prices.
Yeh added, "We are promoting Taiwan as a medical-tourism destination, and we believe that we can attract more patients from Malaysia to Taiwan. Ultimately, we hope to see Taiwan as their top choice for international medical service provider in Asia."
With the success of the recent event, TAITRA intends to continue to promote Taiwan's premium medical services to patients from Malaysia.
For media enquiries, please contact:
Penny Ching
PR /Marketing Executive
Flame Communications
(E):
penny@flamecomms.com
(T): 6259 3193/ 6253 3193
Source: TAITRA
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
September 13 2024 17:50 JST
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
September 05 2024 23:00 JST
Driving Innovations in Technology
September 07 2023 12:00 JST
Driving Innovations in Technology
September 07 2023 09:00 JST
Taiwan Excellence Pavillion Fosters Connections in ASEAN and Beyond Through Successful Debut at AT X SG
June 30 2023 13:00 JST
Taiwan Excellence Showcases over 30 Award-Winning Products at Asia Tech x Singapore 2023 Debut
June 08 2023 09:00 JST
Taiwan Excellence Debuts at ATxSG 2023 with Award-Winning Tech Solutions
May 24 2023 10:00 JST
Taiwan Stays at the Forefront of Medical Technology
September 29 2022 13:00 JST
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
August 19 2022 14:00 JST
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
August 19 2022 14:00 JST
More Press release >>
Latest Press Release
TOPVISION Launches Prospectus for Listing Transfer from LEAP to the ACE Market
Nov 27, 2024 05:53 JST
TOYOTA GAZOO Racing FULLY PREPARED FOR DAKAR 2025
Nov 26, 2024 17:55 JST
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan
Nov 26, 2024 15:50 JST
Fujitsu develops Policy Twin, a new digital twin technology to maximize effectiveness of local government policies for solving societal issues
Nov 26, 2024 10:51 JST
TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025
Nov 25, 2024 17:10 JST
Toyota Submits Progress Report on Recurrence Prevention Measures
Nov 25, 2024 15:43 JST
TOPVISION Launches Prospectus for Transfer Listing from LEAP to the ACE Market
Nov 25, 2024 15:00 JST
MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant
Nov 25, 2024 14:18 JST
Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship
Nov 25, 2024 11:55 JST
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST
ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
More Latest Release >>